Bhupesh Sharma

3.0k total citations · 1 hit paper
91 papers, 2.3k citations indexed

About

Bhupesh Sharma is a scholar working on Neurology, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Bhupesh Sharma has authored 91 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Neurology, 26 papers in Molecular Biology and 16 papers in Cognitive Neuroscience. Recurrent topics in Bhupesh Sharma's work include Neurological Disease Mechanisms and Treatments (24 papers), Neurological Disorders and Treatments (18 papers) and Autism Spectrum Disorder Research (16 papers). Bhupesh Sharma is often cited by papers focused on Neurological Disease Mechanisms and Treatments (24 papers), Neurological Disorders and Treatments (18 papers) and Autism Spectrum Disorder Research (16 papers). Bhupesh Sharma collaborates with scholars based in India, United States and Nepal. Bhupesh Sharma's co-authors include Nirmal Singh, Surbhi Gupta, Giriraj T. Kulkarni, Amteshwar Singh Jaggi, Rajendra Awasthi, Prabhat Singh, Neerupma Dhiman, Harsha Kharkwal, Manjeet Singh and Vijay Pal Singh and has published in prestigious journals such as Brain Research, Neuroscience and Neuroscience & Biobehavioral Reviews.

In The Last Decade

Bhupesh Sharma

86 papers receiving 2.3k citations

Hit Papers

Lipid Nanoparticles as Carriers for Bioactive Delivery 2021 2026 2022 2024 2021 50 100 150 200

Peers

Bhupesh Sharma
Bhupesh Sharma
Citations per year, relative to Bhupesh Sharma Bhupesh Sharma (= 1×) peers Shui‐bing Liu

Countries citing papers authored by Bhupesh Sharma

Since Specialization
Citations

This map shows the geographic impact of Bhupesh Sharma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bhupesh Sharma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bhupesh Sharma more than expected).

Fields of papers citing papers by Bhupesh Sharma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bhupesh Sharma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bhupesh Sharma. The network helps show where Bhupesh Sharma may publish in the future.

Co-authorship network of co-authors of Bhupesh Sharma

This figure shows the co-authorship network connecting the top 25 collaborators of Bhupesh Sharma. A scholar is included among the top collaborators of Bhupesh Sharma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bhupesh Sharma. Bhupesh Sharma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gupta, Surbhi, Prabhat Singh, & Bhupesh Sharma. (2024). Montelukast Ameliorates 2K1C-Hypertension Induced EndothelialDysfunction and Associated Vascular Dementia. Current Hypertension Reviews. 20(1). 23–35. 4 indexed citations
2.
Sharma, Bhupesh, et al.. (2024). ML218 modulates calcium binding protein, oxidative stress, and inflammation during ischemia-reperfusion brain injury in mice. European Journal of Pharmacology. 982. 176919–176919. 6 indexed citations
4.
Kumar, Gulshan, Bhupesh Sharma, Rajesh Kumar, et al.. (2023). Design and Synthesis of C-8 spiro-isoxazoline analogues of 14-Deoxy-11,12-didehydroandrographolide (14-DDA) for dual targeting of CDK4 and BCL2 mediated anticancer activity. Journal of Molecular Structure. 1298. 137072–137072. 4 indexed citations
5.
Kharkwal, Harsha, et al.. (2022). Salubrious effects of ulinastatin and quercetin alone or in combination in endothelial dysfunction and vascular dementia. Pharmacological Reports. 74(3). 481–492. 7 indexed citations
7.
Sharma, Bhupesh, et al.. (2022). Protective Effect of Nimodipine Against Valproic-acid Induced Biochemical and Behavioral Phenotypes of Autism. Clinical Psychopharmacology and Neuroscience. 20(4). 725–736. 7 indexed citations
8.
Sharma, Bhupesh, et al.. (2022). Remediate Effect of Ryanodine Receptor Antagonist in Valproic-Acid Induced Autism. Biomedical & Pharmacology Journal. 15(1). 59–71. 3 indexed citations
9.
Sharma, Bhupesh, et al.. (2021). PDE3 Inhibition by Cilostazol Ameliorated Behavioral and Biochemical Deficits in Prenatal Alcohol Induced Experimental ADHD. Current Enzyme Inhibition. 17(2). 111–119. 1 indexed citations
10.
11.
Singh, Prabhat & Bhupesh Sharma. (2020). Agonism of Histaminergic-H1 Receptors in Ischemic Postconditioning During Cerebral Ischemia-Reperfusion Injury is Protective. Current Neurovascular Research. 17(5). 686–699. 8 indexed citations
12.
Kulkarni, Giriraj T., et al.. (2020). Possible involvement of D2/D3 receptor activation in ischemic preconditioning mediated protection of the brain. Brain Research. 1748. 147116–147116. 10 indexed citations
13.
Sharma, Bhupesh, et al.. (2019). Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats. Brain Research Bulletin. 147. 36–46. 62 indexed citations
14.
15.
16.
Sharma, Bhupesh, et al.. (2015). Neuroprotective effect of selective DPP-4 inhibitor in experimental vascular dementia. Physiology & Behavior. 152(Pt A). 182–193. 33 indexed citations
17.
18.
Gupta, Surbhi & Bhupesh Sharma. (2014). Pharmacological benefit of I1-imidazoline receptors activation and nuclear factor kappa-B (NF-κB) modulation in experimental Huntington's disease. Brain Research Bulletin. 102. 57–68. 21 indexed citations
20.
Gupta, Surbhi & Bhupesh Sharma. (2013). Pharmacological modulation of I1-imidazoline and α2-adrenoceptors in sub acute brain ischemia induced vascular dementia. European Journal of Pharmacology. 723. 80–90. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026